Amgen's George Rathmann dies at 84
This article was originally published in Scrip
George Rathmann, founding CEO of Amgen, has died aged 84 as a result of complications from pneumonia. Mr Rathmann served as Amgen's CEO from 1980 to 1988 and as board chair until 1990, and was regarded as one of the founding fathers of biotechnology. On leaving Amgen, he became CEO and chair of Settle-based biotech ICOS Corporation, which was acquired by Lilly, and subsequently CEO and chair of genomics company Hyseq.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.